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Thin living tissue slices have recently emerged as a new tissue model for cardiac
electrophysiological research. Slices can be produced from human cardiac tissue, in
addition to small and large mammalian hearts, representing a powerful in vitro model
system for preclinical and translational heart research. In the present protocol, we
describe a detailed mouse heart transverse slicing and optical imaging methodology.
The use of this technology for high-throughput optical imaging allows study of
electrophysiology of murine hearts in an organotypic pseudo two-dimensional model.
The slices are cut at right angles to the long axis of the heart, permitting robust
interrogation of transmembrane potential (Vm) and calcium transients (CaT) throughout
the entire heart with exceptional regional precision. This approach enables the use
of a series of slices prepared from the ventricles to measure Vm and CaT with high
temporal and spatial resolution, allowing (i) comparison of successive slices which form
a stack representing the original geometry of the heart; (ii) profiling of transmural and
regional gradients in Vm and CaT in the ventricle; (iii) characterization of transmural and
regional profiles of action potential and CaT alternans under stress (e.g., high frequency
pacing or β-adrenergic stimulation) or pathological conditions (e.g., hypertrophy). Thus,
the protocol described here provides a powerful platform for innovative research on
electrical and calcium handling heterogeneity within the heart. It can be also combined
with optogenetic technology to carry out optical stimulation; aiding studies of cellular Vm
and CaT in a cell type specific manner.
Keywords: optical mapping, transverse cardiac slice, membrane potentials, Ca2+ transients, murine heart
INTRODUCTION
Thin living tissue slices are a widely used experimental preparation for electrophysiological studies
of the brain (Accardi et al., 2016). Slices have recently been adopted as a promising model for the
investigations of cardiac electrophysiology in different species, for example: viral delivery, culturing,
and mechanical stimulation (Halbach et al., 2006; Bussek et al., 2009; Camelliti et al., 2011;
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Wang et al., 2015; Kang et al., 2016; Thomas et al., 2016;
Randi et al., 2017; Watson et al., 2017, 2019; Wen et al., 2018).
Importantly, cardiac slices exhibit similar electrophysiological
characteristics to the intact heart and respond to the application
of pharmacological compounds similarly to the whole heart
(Bussek et al., 2009; Camelliti et al., 2011; Wen et al., 2018).
They have advantages for investigating transmural and regional
characteristics of a variety of physiological parameters of
the heart, thus providing a promising experimental model
for heart research.
Because of feasibility for genetic modification, the mouse
has been widely used for exploring molecular, cellular and
systemic mechanisms underlying inherited and acquired cardiac
arrhythmic diseases (Nerbonne and Kass, 2005; Huang, 2017).
Despite the popularity of mouse models in cardiac arrhythmic
research, cardiac transmural heterogeneities of action potential
and Ca2+ transient characteristics, which are vitally important
for phenotypic and mechanistic research in cardiac disease
conditions, have only been explored recently in the mouse
heart (Wen et al., 2018). We reported a robust approach for
transverse cardiac slicing and optical mapping of transmembrane
potential (Vm) and intracellular Ca2+ transient (CaT) in
murine hearts, providing unprecedented and potentially high-
throughput characterization of action potentials (APs) and
intracellular Ca2+ transients everywhere in the mouse ventricles
(Wen et al., 2018). Such an approach can be potentially adapted
for large mammalian hearts and human tissue, thus representing
a powerful in vitro model system for translational cardiovascular
research (Thomas et al., 2016; Randi et al., 2017; Watson et al.,
2017, 2019). Using this technique, we demonstrated the feasibility
of our new approach to cardiac slicing for systematic analysis of
intrinsic transmural and regional gradients in Vm and CaT in
murine ventricular tissue (Wen et al., 2018).
In the present protocol, we describe a detailed feasible
transverse slicing method, cutting slices at right angles to the
long axis of the heart and combined it with a high-throughput
optical imaging technique as a new approach for studying
cellular electrophysiology of murine heart in an organotypic
pseudo two-dimensional ventricular tissue model. Our method
enables the use of a series of slices prepared from the ventricles
to simultaneously measure Vm and CaT with high temporal
and spatial resolution allowing comparison of transmural and
regional profiles of APs and CaTs. This technique can potentially
be combined with other molecular techniques such as in situ
immunostaining and virus transfection to gain insight into
arrhythmia mechanisms in various heart disease conditions.
MATERIALS AND EQUIPMENT
Animals
Animals used were 10–12 weeks, 20–25 g, male C57BL mice or
Pnmt-Cre/ Channelrhodopsin 2 (ChR2) mice as we previously
reported (Wang et al., 2017). The Pnmt-Cre/ChR2 mouse
line exhibits cell-type specific expression of ChR2 by crossing
B6.Cg-Gt (ROSA)26Sortm27.1(CAG−COP4H134R/tdTomato)Hze/J
strain (Stock No. 012567, Jackson Labs) with a Cre transgenic
strain under the control of a Pnmt promoter (Wang et al., 2017).
ChR2 was specifically introduced into murine cells expressing
the Phenylethanolamine n-methyltransferase (Pnmt) gene,
which encodes for the enzyme responsible for conversion
of noradrenaline to adrenaline. The murine model led to
the identification of a distinctive class of Pnmt-expressing
neuroendocrine cells and their descendants (i.e., Pnmt+ cell
derived cardiomyocytes) within the heart (Wang et al., 2017).
All procedures including animal subjects have been
approved by Institutional Animals Ethics Committees at
Southwest Medical University, Luzhou, China or Department
of Pharmacology at University of Oxford, United Kingdom and
the national guidelines under which the institution operates. All
mice used in this study were maintained in a pathogen−free
facility at Southwest Medical University or University of Oxford.
Mice were given ad libitum access to food and water. The authors
confirm that they have taken all steps to minimize the animals’
pain and suffering.
Chemicals and Reagents
The relevant information of the chemicals and reagents are
described in Table 1.
Instruments and Equipment
- Dumont forceps (Medical Equipment Factory of Shanghai
Medical Instruments Co., Ltd., Shanghai, China).
- Mayo scissors (Medical Equipment Factory of Shanghai
Medical Instruments Co., Ltd., Shanghai, China).
- Kelly hemostatic forceps (Medical Equipment Factory of
Shanghai Medical Instruments Co., Ltd., Shanghai, China).
- Iris forceps (Medical Equipment Factory of Shanghai
Medical Instruments Co., Ltd., Shanghai, China).
- Syringe Filter, Aquo-system, 0.45 µm/13 mm (Sangon
Biotech Shanghai, China, F513143-0001).
- Langendorff perfusion system.
- Perfusion pump (Longer Precision Pump Co., Ltd.,
Baoding, China, BT100-2J).
- Vibration slicer (Leica VT1000s, Nussloch, Germany).
- EMCCD camera (Evolve 512, Photometrics, Tucson,
AZ, United States).
- MacroLED light source (Cairn Research, Faversham,
United Kingdom).
- MyoPacer EP field stimulator (Ion Optix Co., Milton, MA,
United States S006152).
- Electrical stimulation chamber (custom-made by
the workshop of Department of Pharmacology,
University of Oxford).
- Heater Controller (custom-made by the workshop of
Department of Pharmacology, University of Oxford).
Solutions
- Krebs solution (containing in mM: NaCl 119, NaHCO3
25, NaH2PO4 1.0, KCl 4.7, MgCl2 1.05, CaCl2 1.35, and
glucose 10; equilibrated with 95% O2/5% CO2, pH 7.4) at
37◦C, pH = 7.35–7.4.
- HEPES buffered BDM solution (in mM: NaCl 140; KCl 4.7;
glucose 10; HEPES 10; MgCl2 1.05; CaCl2 1.35; pH 7.4)
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TABLE 1 | Reagents utilized.
Chemical and catalog references Supplier
NaCl (SLBS2340V) Sigma-Aldrich, St. Louis, MO, United States
NaHCO3 (SLBX3605) Sigma-Aldrich
NaH2PO4 (BCBW9042) Sigma-Aldrich
KCl (SLBS5003) Sigma-Aldrich
MgCl2 (BCBS6841V) Sigma-Aldrich
CaCl2 (SLBK1794V) Sigma-Aldrich
Glucose (SLBT4811V) Sigma-Aldrich
HEPES (W1122DO10) Sangon biological, Shanghai, China
2,3-butanedione monoxime (BDM) (29297) Sigma-Aldrich
Blebbistatin (SLBV5564) Tocris Bioscience, Minneapolis, MN, United States
Voltage-sensitive dye RH237 (1971387) Thermo Fisher Scientific, Waltham, MA, United States
Calcium indicator Rhod-2AM (1890519) Invitrogen, Carlsbad, CA, United States
Dimethyl sulfoxide (DMSO) (RNBT7442) Sigma-Aldrich
Heparin Sodium (H51021209) Chengdu Haitong Pharmaceutical Co., Ltd., Chengdu, China
Avertin (2,2,2-tribromoethanol) Sigma-Aldrich Poole, Dorset, United Kingdom
Pluronic F127 (1899021) Invitrogen, Carlsbad, CA, United States
Low-melt agarose (A600015.0005) BBI Life Sciences, Shanghai, China
containing the excitation–contraction uncoupler 2,3-
butanedione monoxime (BDM, 10 mM) and was stored
at 4◦C.
- Blebbistatin stock solution, 10 mM in DMSO.
- Voltage-sensitive dye RH237 stock solution,
1.25 mg/mL in DMSO.
- Calcium indicator Rhod-2AM stock solution,
1 mg/mL in DMSO.
Preparation of Experimental Setup(s)
- Prepare the Langendorff perfusion system. Turn on the
perfusion system pump. Starting the peristaltic pump
that is used for retrograde perfusion. Wash the perfusion
system with 1 L deionized water with initial flow rate at
90 ml/min. Once all the deionized water has evacuated
from the chamber, circulate the Krebs solution and pass
it through a 0.45 µm filter. Keep Krebs solution at 37◦C
with a water jacket, circulated and oxygenated by bubbling
O2/CO2 (95%/5%) gas into the solution. Adjust the flow
rate to 4 ml/min.
- Prepare the optical mapping system (Figure 1), a custom-
designed system equipped with an EMCCD camera. The
excitation light for Ca2+ sensitive dye Rhod-2 and voltage
sensitive dye RH237 is provided by four MacroLED lamps
(525 nm, 1750 lumen, 7 mm2 emitters, Cairn Research)
with aspheric condensers driven using MacroLED control
boxes and digitally modulated from Metamorph software.
LEDs are directed onto the slices from the four corners of
the bath, to produce an even, near-critical, illumination at
approximately 30 mm, with equal distance from 4 corners.
An ET525/50 sputter coated filter (Chroma Technology) is
used to remove any out-of-band light for each LED.
Samples are imaged using a custom MacroScope (Cairn
Research) with an F/0.95, 25 mm C-mount camera lens,
spaced to give a working distance of approximately 40 mm.
The fluorescence emission light is split with a 635 nm
longpass dichroic mirror and subsequently filtered (Vm:
662 nm LP, CaT: 585/40 nm) to separate the Ca2+
and voltage signals based on their wavelengths using the
OptoSplit apparatus (Cairn Research). Once split, the Vm
and CaT signals are imaged on to the camera such that they
are reproduced side-by-side on the sensor and recorded
simultaneously (Vm imaged on one side of the chip,
CaT on the other).
- Prepare the vibratome. Install a new blade at the holder and
fill the cooling chamber with crushed ice.
PROCEDURE
Figure 2 shows the major steps of the protocol.
Harvest, Cannulation, and Perfusion of
Mouse Heart (30 min)
(1) Anesthetize the animal with 1.2% Avertin solution (0.5–
0.8 ml I.P.) containing heparin (200 units I.P.), ensuring
lack of pain reflex, prior to sacrifice (Complete in 10 min).
(2) Open the chest, quickly remove the heart and keep the
heart in oxygenated (95% O2, 5% CO2), (37 ± 1◦C) Krebs
solution. Using a dissecting microscope, identify the aorta
and make a clean cut across the ascending aorta below
the right subclavian artery. Cannulate the aorta onto a
custom-made cannula and tie with 4-0 black-braided silk
suture around the cannula. After cannulation, retrogradely
perfuse the heart and superfuse with constant-temperature
(37 ± 1◦C) Krebs solution. The retrograde perfusion rate
was adjusted in the range of 3.5–4.0 mL/min (Complete
this step in 3 min).
(3) Important! Insert a small silicon tube (0.7 mm diameter)
into the left ventricular cavity through the left atrial
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FIGURE 1 | Optical mapping set-up. The system consists of a camera (Photometrics Evolve Delta 512) running under Metamorph (Molecular Devices) in
Light-speed mode, giving a high temporal resolution of sub-frames, up to 1000 frames/sec, and spatial resolution at the sample of 74 × 74 µm per pixel. The
sample was imaged using a custom MacroScope (Cairn Research) with an F/0.95, 25 mm C-mount camera lens, spaced so as to give a working distance of
approximately 40 mm. The excitation light was provided by a four light emitting diode MacroLED lamps (525 nm, 1750 lumen, 7 mm2 emitters, Cairn Research) with
aspheric condensers directed onto the slices from the four corners of the bath, so as to produce an even, near-critical, illumination at approximately 30 mm. The
LEDs were driven using MacroLED control boxes and digitally modulated from Metamorph software with a National Instruments multifunction card. The LEDs were
individually filtered using ET525/50 sputter coated filters (Chroma Technology) to remove any out-of-band light. The fluorescence emission light was split with a
610 nm long-pass dichroic mirror and corresponding emitters to separate the Ca2+ and voltage signals based on their wavelengths. The voltage-sensitive dye,
RH237, emits signals which exhibit a peak at 670 nm, while Rhod-2 AM has a peak emission at approximately 600 nm and, once split by the dichroic mirror, these
two signals are imaged on to the camera such that they are reproduced side-by-side on the sensor and recorded simultaneously. This dichroic and adjustable mirror
unit, the OptoSplit, was provided by Cairn Research with filters from Chroma Technologies (United States). CaT fluorescence was collected at 585 ± 40 nm and Vm
using a 662 nm long pass filter. Vm and CaT measurements were taken at maximal resolution (128 × 128 pixels; pixel area 74 × 74 µm) at a rate of 1000 frames/s.
FIGURE 2 | The major steps of the protocol. Representative harvested mouse heart and transverse slices from apex to base. Briefly, after the Langendoff perfusion
steps (A), embed the heart in 4% low-melting agarose and cut with right angle to the long axis by Leica VT1000s vibratome (B). Slices are transferred to petri dishes
(C) and voltage and calcium transients recorded (D).
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appendage in order to prevent ventricular pressure
increasing due to solution congestion and to prevent
acidification of the perfusate trapped in the left
ventricular cavity. This is especially important after
the suppression of ventricular contractions with an
excitation-contraction uncoupler.
After the dyes are loaded, the steps described in Sections
“Chemicals and Reagents,” “Instruments and equipment,” and
“Solutions” should be performed in the dark.
Load Calcium and Voltage Sensitive
Dyes and Excitation-Contraction
Uncoupler (50–60 min)
(1) Before dye loading, ensure the isolated heart is beating
rhythmically without ischemia (10 min).
(2) Mix 50 µl calcium indicator Rhod-2 AM 1:1 with Pluronic
F127 (20% solution in DMSO) and then dilute in 1 ml
Krebs solution. Recirculate oxygenated (95% O2, 5% CO2)
Krebs solution at constant-temperature (37 ± 1◦C) and
then inject Rhod-2 AM solution slowly over 7–10 min
through the injection port near the cannula.
(3) Continue to recirculate Krebs solution after finishing
injection (now, the perfusate contains Rhod-2 AM and
Pluronic F127) (20 min).
(4) During this time, dilute 30 µl voltage-sensitive dye RH237
(1.25 mg/ml stock) in 1 ml Krebs solution.
(5) Switch to perfusion with oxygenated (95% O2, 5% CO2),
constant-temperature (37 ± 1◦C), Krebs solution and
perfuse the heart for 2–3 min. Then inject RH237 solution
slowly over 7–10 min through the injection port.
(6) After loading the voltage dye, recirculate oxygenated
Krebs solution containing 10 µM blebbistatin [maintaining
constant temperature at 37 ± 1◦C] until the heart stops
beating (10–15 min).
(7) Whilst waiting for the heart to stop beating, prepare
equipment and solutions for ventricular slicer. A standard
razor blade is cut into half and placed on the blade holder
so that the blunt side of the blade was tight up against
the holder. A circle of solidified agar is mounted on the
ventricular slicer’s plunger using superglue.
Ventricular Slicing, Harvest, and
Recovery (60–70 min)
(1) Take the heart off the Langendorff setup.
(2) Carry out all dissections in ice cold HEPES buffered BDM
solution. Remove atria and connective tissue from the
ventricles to flatten the base.
(3) Mount base of the heart on solidified 4% agarose of slicer’s
plunger using surgical glue.
(4) Freshly prepare 4% low-melt agarose, cool on ice, and pour
to cover the whole heart. Surround the plastic cap with
the metal support.
(5) After the agarose is solidified, place the ventricular slicer
plunger inside the metal merged into vibratome bath until
it reaches stop point. Fill the ventricular slicer bath with
ice-cold HEPES buffered BDM solution.
(6) Cut slices transversally at a thickness of 300–350 µm, with
speed of 0.05 mm/s, amplitude of 1 mm and vibration
frequency of 80 Hz (2 min per slice).
(7) On average 14 ventricular slices are harvested. Transfer
each slice (other than the first which was usually discarded)
to a petri dish containing ice-cold HEPES buffered BDM
solution for 10 min. Pin the slices on small pieces of thin
square shape Sylgard sheets (1 × 1 cm in diameter, 0.2 cm
thickness), cover with mesh. Then transfer the slices to 1st,
2nd, and 3rd petri dishes filled with oxygenated blebbistatin
Krebs solution (10 µM) at room temperature (RT) for
10 min in each dish.
(8) Repeat slicing procedure until the last slice is harvested.
Optical Mapping
(1) Place each slice in oxygenated blebbistatin Krebs solution
(10 µM) in 37◦C tissue bath for 2–3 min to equilibrate.
(2) Place the slice into a custom-made stimulation chamber
filled with 37◦C oxygenated blebbistatin Krebs solution
(10 µM) between the two pacing electrodes. Use pin(s) and
mesh to flatten the slice.
(3) Place the slices into the optical mapping setup (Figure 2,
details in Materials and equipment). For field pacing,
stimulate with square pulses of 2 ms duration, at voltages
1.5 times above threshold (minimum voltage required to
pace tissue) with 1:1 coupling.
(4) For optical pacing, the tissues are paced through the
activation of ChR2 light-sensitive channels. This is achieved
by the delivery of 470 nm blue light pulses (2–10 ms
pulse width) generated by OptoFlash (Cairn Research,
Faversham, United Kingdom). Pulses are triggered by a
1401 digitiser and Spike 2 software (Cambridge Electronic
Design). Approximate blue light intensity is measured with
a 818-ST2 Wand Detector connected to a 843 R Power
meter (both Newport Corporation, CA, United States) and
we estimate an average irradiance in our experiments of
0.1–0.3 mW/mm2 based on an approximate distance of
1–2 cm between Sylgard and liquid light guide (Oriel
instruments Model No 77525).
(5) For AP and CaT alternans investigations, stimulate slices at
frequencies of 2, 4, 8 and 16 Hz. Between pacing protocols,
turn off the LED lights to minimize photobleaching (and
other possible side effects, including phototoxicity). When
testing, turn off the oxygenation to avoid motion artifacts.
(6) After experiment is finished, clean the perfusion system
with deionized water.
Data Analysis
(1) Recorded image files are loaded into an optical mapping
analysis software ElectroMap1 (O’Shea et al., 2019). Pre-
process images with application of 3 × 3 pixel Gaussian
spatial filter and top-hat (kernel length = 100 ms)
baseline correction.
1https://github.com/CXO531/ElectroMap
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(2) Measure action potential duration (APD)/Calcium
transient duration (CaTD) at desired repolarization/decay
percentage at each pixel across the tissue, as measured
from time of maximum upstroke velocity. Voltage-calcium
latency can be measured as time difference between
AP and CaT peak.
(3) For assessment of conduction velocity, render activation
map by measuring activation time, for example by
measuring depolarization midpoint or upstroke time
(dV/dt max). Conduction velocity across the slice can then
be quantified using multi-vector polynomial method with a
local window size of 5× 5 pixels (Bayly et al., 1998).
Exemplar Results
Figure 1 shows the optical mapping set-up. After the slices
were prepared, slices were pre-incubated at room temperature
in Krebs solution containing 10 µM blebbistatin for an optimal
recovery time, prior to electrophysiological assessment using a
custom-designed optical mapping system.
Figure 2 shows the major steps of the protocol. To achieve
optimal dye loading, the voltage dye RH237 and/or Ca2+ dye
Rhod-2 AM were loaded through the coronary circulation using
the Langendorff perfusion system (Figure 2A). Prevention of
blood clot formation was essential for optimal dye loading and
was achieved by initial injection of heparin (200–300 units)
before animal sacrifice. Ventricles were embedded in low-melting
temperature agarose as illustrated in Figure 2B to provide
structural support to the tissue during sectioning. Slices were
cut at right angles to the long axis of the heart from the
apex to the base, and thicknesses from 300–350 µm found
to be the best thickness to achieve optimal recordings for
both Vm and CaT (Figure 2B). Figure 2C shows viable slices
obtained with the optimized protocol and representative Vm
and CaT signals.
Figure 3A shows fluorescence images of voltage dye RH237
and Ca2+ dye Rhod-2 AM as imaged using the optical mapping
setup. Using this protocol, and the optical imaging setup, we
are able to dually measure parameters such as AP duration
(Figure 3B) and CaT duration and (Figure 3C). The “rundown”
of the Vm and CaT signals was monitored for up to 4 h, the
average signal “rundown” being less than 25%. Our experiments
usually finished within 3 h from the beginning of Langendorff
perfusion of the heart.
Figure 4 shows an example of activation (Figure 4A) and
APD75 (Figure 4B) maps reconstructed from electrical and light-
paced APs in a ventricular slice from Pnmt-Cre/ChR2 mouse
heart. Also shown are exemplar Vm signals from different regions
of the ventricle.
DISCUSSION
The protocol described here allows high resolution mapping
of Vm and CaT on thin transverse slices cut at right angles
to the long axis of the heart, permitting robust interrogation
of Vm and CaT throughout the entire heart with exceptional
regional precision. Since the apico-basal location of each
FIGURE 3 | Dual Vm and CaT imaging in murine transverse ventricular slices.
(A) Fluorescence image (voltage-RH237) of transverse slices of murine
ventricles from apex to base, dual loaded with both transmembrane voltage
(RH237) and intracellular calcium dyes (Rhod-2 AM). (B) Representative maps
of AP duration (APD50) at 2 Hz pacing frequency (500 ms pacing cycle length)
recorded from apex to base ventricular slices. (C) Representative maps of
Calcium transient duration (CaTD50) at 2 Hz pacing frequency recorded from
apex to base ventricular slices.
slice is known and every slice is fully transmural, such rich
data allows for characterization of regional AP and CaT
properties. This includes AP and CaT durations, alternans
threshold, transmural activation and conduction velocities, and
correlation of AP and CaT properties such as voltage-calcium
coupling latency in each slice. The main processes of the
protocol include: (i) Preparing solutions and experimental
setup; (ii) Harvesting, cannulation and perfusion of the mouse
heart by Langendorff perfusion; (iii) Loading calcium and
voltage sensitive dyes and excitation-contraction uncoupler; (iv)
Ventricular Slicing; (v) Optical mapping; (vi) Image processing
and analysis. The protocol was further developed since it
was first published (Wen et al., 2018) in two major aspects:
(i) simultaneous dual dye images allowing correlation of AP
and CaT properties in each slice; (ii) implementing improved
image processing and analysis such as correlation of AP
and CaT properties.
Applications
Our novel approach potentially provides not only a unique
technique applicable to hearts of other species (such as
widely used rat and rabbit), but also other tissues such as
brain, adrenal medullary tissue, gut, etc. As we demonstrate
here (Figure 4), such slice imaging technique can be
also combined with optogenetic technology to carry out
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FIGURE 4 | Comparison of electrical (field stimulation) and light (470 nm pulses) pacing in murine transverse ventricular slices. (A) Activation map and example
signals (transmembrane voltage, RH237) from slice paced using electrical field stimulation. (B) Activation map and example signals from the same slice paced using
blue light stimulation of ChR2. (C) APD75 map from slice during electrical field stimulation. (D) APD75 map from slice during blue light stimulation.
optogenetic light stimulation of specific cells. Such an approach
could be further extended by use of genetically encoded
reporter proteins allowing cell-type specific study of Vm
and Ca2+ signals, as well as cell-specific activation. We
believe that the approach would be of considerable interest
to researchers in manifold biomedical research fields and
would serve as a useful platform for further innovative
biomedical research.
Advantages
Firstly, a critical advantage of our cardiac slice model is the
ability to provide access to any region of the ventricles, thus
enabling exploration of regional and transmural differences.
This is particularly important for the mouse heart, given
that other in vitro tissue preparations, such as ventricular
wedges, are not feasible for small hearts. Secondly, this
technique may prove extremely valuable for characterizing
regional arrhythmogenic changes in genetic murine models
of cardiovascular disease (e.g., catecholaminergic polymorphic
ventricular tachycardia, hypertrophic cardiomyopathy), as well
as comprehensive regional characterization of remodeling in
acquired pathologies (myocardial infarction, pressure-overload
heart failure). Thirdly, depending on the optics, camera
resolution, and slice size and position, it may be possible to image
several or all slices from a single mouse heart simultaneously,
giving a high throughput platform to electrophysiological
investigations. Finally, it can also be combined with optogenetic
technology to carry out optogenetic light stimulation –
aiding studies requiring precise manipulation of cellular
Vm and CaT.
Limitations and Adaptations
(i) Possibility of tissue injury increasing regional Vm and CaT
differences. This can be overcome by optimized protocol with
very slow cutting speed, embedding in supportive but oxygen
permeable medium, and use of blebbistatin as uncoupler during
slice preparation. (ii) Rundown of the Vm and CaT signals. The
“rundown” of the Vm and CaT signals was also monitored for up
to 4 h, the average signal “rundown” being less than 25%. Our
experiments usually finished within 3 h. This can be overcome
by efficient imaging processes, and the application of 0.5 mM
Probenecid in the recovery and recording solutions to reduce the
Ca2+ dye loss. (iii) The measurements of the parameters under
electrical pacing condition was conducted by field stimulation
(considering the fragile dedicated slice preparation), thus our
approach may suffer from tissue activation occurring at the same
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time point across the preparation. Whilst this is not what we
observed regularly in our data, this approach may affect the
conduction velocity (CV) measurement. A better approach with
point stimulation or selective optical activation of a subset of cells
(Figure 4) should be pursued.
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